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The polyherbal formulation chandraprabha vati (CV) comprising 29 herbs is traditionally used as an anti-inflammatory 
agent for arthritis and urinary ailments in Indian Siddha medicine. Earlier, we reported that lipopolysaccharide (LPS) 
induced apoptosis in RAW 264.7 macrophages is mediated by hydrogen sulfide (H2S), a potential target for many 
inflammatory diseases. Here, we hypothesized that pretreatment with CV decreases H2S level and thereby alleviate the 
inflammatory conditions induced by LPS in RAW 264.7 macrophages, and this protective effect occurs through alterations 
in cystathionine-γ-lyase (CSE), a H2S synthesizing enzyme. Accordingly, we evaluated the anti-inflammatory effect of CV 
in LPS-stimulated RAW 264.7 macrophages in vitro. The CV pretreatment followed by 12 h of LPS-stimulation showed 
significantly decreased TNF-α, H2S production possibly through CSE gene expression and NF-кB activation compared to 
the non pretreated macrophages. Our results further confirm that the polyherbal extract chandraprabha vati may be a useful 
therapy for inflammatory disorders by reducing H2S levels. 
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Inflammation is a tightly regulated pathophysiological 
process, including the production of inflammatory 
mediators that initiate and maintain inflammatory 
response1. Macrophages play a critical role during 
inflammation2 and activated macrophages induce 
inflammation via the release of numerous mediators 
including the gaseous mediators such as nitric oxide3 
and hydrogen sulfide4. Though not studied in detail, 
previous studies have shown the involvement of 
hydrogen sulfide as a crucial player in several 
inflammatory conditions6. 
Previous studies have shown that H2S, a gaseous 
mediator, plays an important role in regulating acute 
inflammatory processes6. Cystathionine-γ-lyase (CSE) 
is the primary regulator of H2S production in the 
normal vasculature and heart5, however, in 
inflammation-associated tissue damage there is 
excessive production of H2S. Accordingly, literature 
suggest that H2S levels increase during the 
pathogenesis of variety of inflammatory diseases in 
rodent models6. Thus, the level of H2S may reflect the 
degree of inflammation and provides an indicator to 
assess inflammatory processes. Blockage of H2S 
production with DL-propargylgycine (CSE inhibitor)6, 
and CSE gene silencing (small interfering RNA)7 has 
been shown to ameliorate inflammation, suggesting 
that endogenous H2S has an important role in the 
pathophysiology of inflammation8. In addition, H2S 
activates the transcription factor nuclear factor-κB 
(NF-κB), required for the activation of several pro-
inflammatory genes in inflammation, indicating the 
important role for H2S in inflammatory signalling6. 
Currently available nonsteroidal anti-inflammatory 
drugs have side effects in inflammation associated 
diseases9. Search for safe and effective new drugs to 
regulate the inflammatory process indicates various 
herbs to possess significant anti-inflammatory effect, 
which may be a helpful adjunct in reducing the 
severity of inflammation. 
Chandraprabha vati (CV) is a polyherbal 
formulation listed in Ayurvedic formulary of India110 
consisting cumulatively of 29 herbs (Acorus calamus, 
Cyperus rotundus, Phyllanthus niruri, Tinospora 
cordiofolia, Curcuma longa, Berberis aristata, Piper 
longum, Coriandrum sativum, Terminalia chebula, 
Terminalia belerica, Embelica officinalis, Embelia 
ribes, Zingiber officinale, Piper nigrum, Hordeum 
vulgare, Ipomoea turpethum, Cinnamomum 








wightii, Andrographis paniculata, Scindapsus 
officinalis, Piper retrofractum, Phyllanthus emblica, 
Plumbago zeylanica, Baliospermum montanum, 
Perculina turpethum, Aconitum heterophyllum, 
Elettaria cardamomum and Saraca asoca)10. It has 
been used commonly in the treatment of inflammation 
linked disorders like urinary tract infections, urinary 
calculi, rhinitis, bronchitis, asthma, eczema, dermatitis, 
etc.11. Saralla et al.12 reported the quality, purity  
and strength of Chandraprabha vati. Previously, 
carrageenan induced hind-paw edema model treated 
with CV has demonstrated antiinflammatory response 
by reducing the paw edema13. Though the mechanism 
behind this anti-inflammatory role is not clear, it has 
been reported that CV has phenolics, tannins, steroids 
and alkaloids, which might have played an important 
role in scavenging the free radicals involved in the 
inflammatory cascade13. Additionally, CV treatment 
leads to regulation of proinflammatory cytokines, 
Granulocyte-macrophage colony-stimulating factor 
and Peroxisome proliferator-activated receptor gamma 
(PPAR-), which are primary regulators during the 
inflammatory processes14.  
In the present study, we hypothesized that CV 
pretreatment would decrease the production of H2S in 
LPS-stimulated macrophages and that this effect 
would occur through alterations in cystathionine-γ-
lyase (CSE).  
 
Materials and Methods 
 
Cell culture 
RAW 264.7 cells (established murine macrophage 
cell line for inflammation studies were purchased  
from American Type Tissue Culture Collection 
(ATCC, Rockville, MD) were suspended in complete 
medium; DMEM supplemented with 10% fetal bovine 
serum (FBS), 100 U/mL penicillin, and 100 U/mL 
streptomycin. Cells were plated in 24-well plates at a 
density of 5×105 cells/well. All experiments were 




CV powder (20 g) (CV procured from Impcops, 
Chennai, India) was extracted under reflux with 
methanol (4X50mL) for 15 min. The extract was 
filtered and evaporated completely under pressure. 
Cells were pretreated for 12 hr with or without 
Chandraprabha vati (40 μg/mL) the concentration of 
40 µg/mL of CV corresponds to the therapeutic dose 
prescribed by traditional medical practitioners18 and 
stimulated with LPS (lipopolysaccharide, Sigma 
Aldrich) (1.0 μg/mL). In positive controls, the cells 
were pretreated with aspirin (acetyl salicylic acid) 
(200 μg/mL) (anti-inflammatory agent) for 12 h and 
stimulated with LPS 1μg/mL for 12 h. 
 
MTT assay 
Cell viability was determined using MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] 
assay according to a previously described protocol. 
RAW 264.7 cells, were harvested by trypsinization 
and resuspended at a final concentration of 2×104 
cells/mL in fresh DMEM with 2% FBS. Aliquots of 
100 µL cell suspension were plated in 96-well tissue 
culture plates. In order to detect the cytotoxicity of the 
cells, cells were treated with CV at a concentration 
range 20 and 40 µg/mL for12 h. After 12 h, 20 µL of 
a 5 mg/mL MTT solution was added to each well, and 
the plate was incubated for 4 h, allowing viable cells 
to reduce the yellow MTT to dark-blue formazan 
crystals, which were dissolved in 100 µL of DMSO. 
The absorbance in individual well was determined at 
570 nm using microplate reader [ELx-800 biotek 
absorbance reader]. The cell viability was calculated 
as percentage of viable cells and then plotted on a 
graph. 
 
ELISA for TNF-α 
Treated RAW 264.7 cells were collected and 
immediately frozen at −80°C. The samples were 
analysed for TNF-α level following the protocol 
provided by R&D systems. 
 
Assessment of H2S production: 
Effect of Chandraprabha Vati on release of H2S 
was determined as described previously15. Briefly, 
cells were homogenised in 50 mM ice-cold potassium 
phosphate buffer (pH 6.8). Homogenate was then 
added to microcentrifuge tubes containing 150 μL of 
zinc acetate (1% w/v) to trap H2S. The reaction was 
terminated after 5 min by adding NNDP (dimethyl-p-
phenylenediamine dihydrochloride) sulfate (20 nM in 
7.2 M HCl) and FeCl3 (30 mM in 1.2M HCl). After 
the mixture was kept in the dark for 20 min, TCA 
(10% w/v) was added subsequently and centrifuged at 
4000 rpm for 10 min. For quantification, the absorbance 
of the solution was determined at 670 nm. 
 
Assay of H2S synthesizing activity 
H2S biosynthesis was measured as described 
previously16. Here, the frozen experimental cells were 
thawed on ice and homogenized in ice-cold 100 mM 
potassium phosphate buffer with pH 7.4. The reaction 




mixture in the volume 500 μL) consists of 
homogenate, 10 mM L-cysteine, 2 mM pyridoxal 5’-
phosphate and made up using saline. The reaction was 
performed in tightly sealed eppendorf tubes and the 
reaction was initiated by transferring the tubes from 
ice to a water bath at 37°C. In some experiments, the 
enzymatic reaction was stopped immediately by 
addition of 10% w/v trichloroacetic acid to denature 
protein prior to addition of L-cysteine. After 
incubation for 30 min, 1% w/v zinc acetate was added 
to trap evolved H2S, followed by 10% w/v 
trichloroacetic acid. Subsequently, 20 μM N,N-
dimethyl-p-phenylenediamine sulphate in 7.2 M HCl 
and 30 μM FeCl3 made using 1.2 M HCl were added 
in the 96-well microplate reader and the absorbance 
was measured at 670 nm after 15 min incubation. The 
H2S concentration of each sample was calculated 
against a calibration curve of sodium hydrosulphide 
(NaHS; 3.12–250 μM) and results are expressed as 
nmol H2S formed per mg DNA6. 
 
Semi quantitative PCR 
Total RNA was extracted from cells with TRIzol 
reagent (Sigma Aldrich) according to the 
manufacturer’s protocol and was stored at –80°C until 
required15. The concentration of isolated RNA was 
quantified spectrophotometrically by measuring the 
absorbance at 260 nm, and the integrity was verified 
visually by ethidium bromide staining of 18S and 28S 
rRNA bands on a denaturing 1% agarose gel for 
quality. About 1.0 μg of RNA was reverse transcribed 
into cDNA using verso cDNA Synthesis Kit (Thermo 
scientific) at 25°C for 5 min and 42°C for 30 min, 
followed by 85°C for 5 min. The synthesised cDNA 
was used as a template for PCR amplification by iQ 
Supermix (Bio-Rad). The PCR primers for detection 
of CSE were Sense: 5-GACCTCAATAGTCGGCTT 
CGTTTC-3, Antisense: 5-CAGTTCTGCGTATGCT 
CCGTAATG-3, size 618 bp. The PCR protocol 
consisted of optimized 32 cycles. The reaction 
mixture was first subjected to 95ºC for 3 min for 
activation of polymerase. This was followed by 
amplification cycle consisting of 95ºC for 30 s 
annealing temperature of 60°C and for amplification 
72ºC for 30 s. PCR amplification was performed in 
MyCycler (Bio-Rad, Laboratories). PCR products 
were analysed on 1.5% w/v agarose gels containing 
0.5 μg/mL ethidium bromide and photographed (Gel 
Doc-It Imaging System). β-actin was used as an 
internal control to normalize the signal from genes of 
interest (sense: 5-GGGCTGTATTCCCCTCCATC-3 
antisense: 5-GTCACGCACGATTTCCCTCTC-3; 
22 cycles; Annealing: 61°C). 
 
Real-time PCR 
A total of 100 ng of RNA was used for each real-
time PCR. It was amplified by Light Cycler real time 
PCR machine (Bio-Rad) using SYBR green I master 
mix (Sigma). Gene expression was calculated relative 
to β-actin levels by the comparative ΔCT values 
method. 
 
Nuclear extract preparation and NF-кB-DNA binding assay 
Nuclear extract was prepared from the cells 
according to manufacturer’s protocol (Cayman’s 
Nuclear Extraction kit NF-κB P65 transcription factor 
assay kit it, MI, USA). The binding of NF-кB to DNA 
was measured by ELISA-based. Multiwell plates were 
coated with un-labelled oligonucleotide containing the 
consensus binding site for NF-κB (5-GGGACTTTCC-
3)16. To each well extracted cell nuclear proteins  
(20 µg) were added and incubated for an hr to allow 
NF-κB to bind DNA. After that, antibody against  
NF-κB p65 subunit was used and NF-κB complex 
bound to the oligonucleotide was detected. A 
secondary antibody conjugated to horseradish 
peroxidase provides the basis for the colorimetric 
quantification. 
 
Western blot analysis 
Treated cells were homogenized with radio-
immunoprecipitation assay lysis buffer, protease 
inhibitor and phosphatase inhibitor cocktail (Sigma 
chemicals). The homogenate was centrifuged at 4°C 
for 15 min at 13500 rpm. Using Bio-Rad protein 
assay, protein concentration was determined. Protein 
sample were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred to 
nitrocellulose membrane. To block non-specific 
binding the membranes were incubated with 5% non-
fat milk powder for an hour. The membrane was then 
incubated with primary antibody for IкBα and HPRT 
(1:1000 dilution) (Cell Signalling Technology). After 
this, the membrane was washed 3 times with 0.05% 
Tween 20 in phosphate-buffered solution and 
incubated for one hour in goat antirabbit horseradish 
peroxidase-conjugated secondary antibody (Santa 
Cruz Biotechnology) (1:2000 dilution). After washing 
the membranes were then incubated in SuperSignal 
West Pico chemiluminescent substrate (Pierce, 
Rockford, Ill) and exposed to radiographic films (CL-
XPosure, Pierce). 





All data represent a minimum of 6 experiments and 
are expressed as the value ± the standard deviation 
(SD). The significance of changes was evaluated by 
using one way ANOVA and Tukey′s method was 
used as a post hoc test for the difference between 




Cytotoxic effect of CV on Raw 264.7 murine macrophages 
To study the anti-inflammatory effect of CV, Raw 
264.7 murine macrophages were chosen. The cells 
when treated with 20 and 40 μg/mL of CV did not 
show any cytotoxic effect (Fig. 1). Since, CV did not 
show cytotoxic effect, these doses were used for 
subsequent experiments. 
Treatment of murine macrophages with 1.0 μg/mL 
LPS led to a strong production of the pro-
inflammatory cytokines TNF-α (467.74±73.35 pg/mL,  
P <0.001) (Fig. 2). CV (20 and 40 μg/mL) co-treatment 
significantly reduced LPS-induced TNF-α levels 
(128.68±30.58 pg/mL, P <0.001) in the cells (Fig. 2).  
 
CV inhibits H2S levels by reducing CSE expression in LPS-
stimulated Raw 264.7 macrophages 
As shown in Fig. 3C, CSE mRNA expression 
significantly increased in LPS-induced cells when 
compared with unstimulated cells whereas LPS-
induced CSE mRNA expression was down-regulated 
after CV treatment in the cells. Compared with the 
control group (0.05±0.003 nM), H2S levels 
significantly (0.12±0.02 nM, P <0.001) increased in 
LPS-induced cells. However, after treatment with CV, 
H2S levels significantly (0.08 ± 0.002 nM, P <0.01), 
decreased when compared with LPS treated group 
(Fig. 3 A & B). 
 
 
Fig. 1 — Inhibition of Raw 264.7 cell growth by CV (20 and
40 μg/mL, 12 h incubation) as determined by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.
Cells were exposed for 24 h to the indicated concentrations
of CV. [Values are the mean from three experiments.
(CV, chandraprabha vati)] 
 
Fig. 3 — CV pretreatment attenuated LPS-induced increase in H2S concentration in Raw 264.7 macrophages. Raw 264.7 macrophages
cells were pre-treated with CV (40 μg/mL) 12 h before LPS (1.0 μg/mL) treatment. (A)H2S level; (B) H2S synthesizing enzyme activity, 
was measured as described in Materials and Methods; (C) Semi quantitative RT-PCR detection of CSE mRNA expression. Sample 
loading was normalized with β-actin; and (D) A significant decrease in CSE expression in CV pre-treated cells was observed by real-time 
analysis [Results shown are the mean ± SD of at least six separate determinations. *P <0.001 when LPS treated Raw 264.7 macrophages 
were compared with control cells. ϮP <0.01 when LPS treated cells were compared with CV pre-treated cells. (CV, chandraprabha vati)]
 
 
Fig. 2 — Effect of CV (40 μg/mL) on the proinflammatory 
cytokine TNF-α levels. [Values are expressed as mean ± S.D. 
of at least six separate determinations. *P <0.001 when LPS 
treated Raw 264.7 macrophages were compared with control 
cells. ϮP <0.001 when LPS treated cells were compared with 
CV pre-treated cells. (CV, chandraprabha vati)] 




Effect of CV on IкBα degradation and NF-кB translocation in 
LPS-stimulated murine macrophages. 
On the basis of anti-inflammatory effect evoked by 
CV on TNF-α and H2S responses, we determined 
whether CV regulates LPS-stimulated inflammation 
in terms of IкBα degradation and NF-кB DNA 
binding activity. The result showed that LPS (1.0 μg/mL) 
induced NF-кB DNA binding activity. CV treatment 
decreased LPS (1.0 μg/mL) induced NF-кB DNA 
binding activity in macrophages (Fig. 4B). Western 
blot analysis revealed that LPS treatment induced 
IкBα degradation in the cells, whereas CV treatment 
attenuated LPS-induced IкBα degradation in 
macrophages (Fig. 4A). 
 
Discussion  
In the present study, we evaluated the anti-
inflammatory effect of CV and the mechanism  
using LPS-stimulated RAW264.7 cells. CV at 20 and 
40 μg/mL concentrations did not affect the cell 
viability (Fig. 1). To our knowledge, this is possibly 
the first report on the anti-inflammatory effects of CV 
in LPS-induced macrophages. In this well described 
LPS-stimulated model4,18, we assessed the inhibition 
of proinflammatory cytokine, TNF-α by CV (Fig. 2). 
TNF-α̣ is an early response cytokine in the inflammatory 
process and an important mediator of inflammation19. 
We evaluated the effects of CV pretreatment (12 h) on 
TNF-α production in 12 h LPS-stimulated RAW 264.7 
macrophages. Confirming our hypothesis, LPS treated 
cells showed significant increase in proinflammatory 
cytokine, TNF-α production (467.74±73.35 pg/mL,  
P <0.001) when compared with LPS untreated cells 
(61.07±21.06 pg/mL). However, CV (40 μg) pretreatment 
(128.68±30.58 pg/mL) in LPS stimulated macrophages 
demonstrated a significant decrease in TNF-α  
(P <0.001) (Fig. 2). In most inflammatory conditions, 
the decreased production of TNF-α would imply a 
reduction in inflammation20 and the reduction of  
TNF-α̣ by CV could possibly ameliorate inflammation 
in the clinical conditions. 
Additionally, we have also shown that two potent 
proinflammatory mediators, TNF-α and H2S, have 
two independent pathways in regulating the 
inflammatory process in RAW macrophages4. In this 
study, we also found that H2S has a role in mediating 
the inflammatory effect of LPS, and the herbal 
formulation CV could effectively quench this 
inflammatory mediator. For instance, H2S production 
by unstimulated macrophages is low (0.05±0.003 nM), 
and when stimulated with LPS, there was a significant 
increase in H2S concentrations at 12 h (0.12±0.02 nM, 
P <0.001). This effect was significantly decreased by 
CV pretreatment at a concentration of 40 μg (12 h 
pretreatment) (Fig. 3A). The H2S synthesizing 
enzyme activity was also found to be decreased in CV 
pretreated cells (40 μg) (Fig. 4B). 
A significant portion of H2S is released after 
noxious stimuli like pro-inflammatory cytokines, 
endotoxin, etc., and the level of this response is 
correlating well with the upregulation of CSE gene 
transcription21. Further, the proinflammatory signalling 
role played by H2S is supported by an in vitro study, 
where human monocytes under the influence of H2S 
induced cytokine secretion thereby regulating the 
inflammatory reactions22.  
The decreased H2S production after treatment with 
CV suggested the possibility of modulation of CSE 
gene expression. Hence, we checked the expression 
level of CSE in CV treated macrophages. As shown in 
Fig. 3C, the LPS treated RAW 264.7 cells showed 
distinct increase in CSE expression, and the values 
were ~1.75 fold higher than the control (Fig. 3D). CV 
(40 μg) pretreatment decreased LPS-stimulated CSE 
gene expression at 12 h (~1 fold reduction) (Fig. 3D). 
In these experiments, we were able to demonstrate 
that herbal formulation, CV could significantly 
decrease H2S production in LPS-stimulated murine 
macrophages and that this inhibition is associated 
with altered CSE gene expression. From our findings, 
it is clear that the flavonoids present in CV possess 
considerable anti-inflammatory effect22 especially 
against the H2S -associated inflammatory pathways. 
 
 
Fig. 4 — (A) IκBα phosphorylation was measured in cytosolic
extracts from the same samples by Western blot analysis. Results
of 3 to 6 experiments are shown. *P <0.001 when LPS treated
Raw 264.7 macrophages were compared with control cells.
ϮP <0.05 when LPS treated cells were compared with CV pre-
treated cells. (CV-chandraprabha vati); and (B) NF-κB DNA 
binding activity was measured in nuclear extracts by ELISA. 




On the basis of anti-inflammatory effect evoked by 
CV on TNF-α and H2S response, we next determined 
whether CV regulates LPS-stimulated NF-кB in terms 
of IкBα degradation and NF-кB DNA binding 
activity. The result showed that LPS (1.0 μg/mL) 
induced NF-кB DNA binding activity. CV treatment 
decreased LPS (1.0 μg/mL) induced NF-кB DNA 
binding activity in macrophages (Fig. 4B). Western 
blot analysis revealed that LPS treatment induced 
IкBα degradation in the cells, whereas CV treatment 
attenuated LPS-induced IкBα degradation in 
macrophages (Fig. 4A). It was reported that 
overexpression of CSE led to enhanced activation of 
NF-κB and phosphorylation of IκBα in inflammation6. 
Moreover, previous studies have also reported that 
exogenous H2S induces NF-κB translocation in 
inflammation23. In this study, we found that CV 
decreased LPS-induced NF-κB activation and IκBα 
degradation. Thus, the inhibitory effect of CV on  
NF-κB translocation and inflammation could be via 
H2S signalling mechanism. It has been reported that 
several plant based compounds14-16,24 and menadione25 
that inhibited CSE expression and H2S level lead to 
the attenuation of inflammatory response.  
It is presumed that under pathologic pro-
inflammatory conditions, inhibiting macrophage H2S 
production could possibly attenuate a variety of 
proinflammatory mediators. It has been reported that 
the efficacy of the herbal extract is usually attributed 
to the multiple phytochemicals present in it. It is 
believed that the ayurvedic preparation with 
numerous phytochemical ingredients in it might 
regulate multiple molecular targets thereby providing 
with clinically favouring efficacy than a single-
molecule drug26. The present study supports further 
the work of Weerasekara et al27 and Rajani et al12 by 




Results of this study demonstrate that the polyherbal 
extract Chandraprabha vati (CV @40 μg/mL) exhibit 
promising anti-inflammatory activity against LPS-
stimulated Raw 264.7 macrophages, and one 
prospective machinery is through the suppression of 
H2S. Although the precise mechanism of action of CV 
as an anti-inflammatory agent is yet to be detailed, the 
presence of numerous phytochemicals may 
synergistically contribute to its observed activity. The 
precise role of H2S and its individual molecular 
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